Potassium Carbonate → 1'-[6-(3-methyl-1,2,4-thiadiazol-5-yl)pyridazin-3-yl]spiro[indene-1,4'-piperidin]-3(2H)-one
Reaction equation
[NH:1]1[CH2:6][CH2:5][C:4]2([C:14]3[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=3)[C:8](=[O:15])[CH2:7]2)[CH2:3][CH2:2]1.Cl[C:17]1[N:18]=[N:19][C:20]([C:23]2[S:27][N:26]=[C:25]([CH3:28])[N:24]=2)=[CH:21][CH:22]=1.C(=O)([O-])[O-].[K+].[K+]>>[CH3:28][C:25]1[N:24]=[C:23]([C:20]2[N:19]=[N:18][C:17]([N:1]3[CH2:6][CH2:5][C:4]4([C:14]5[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=5)[C:8](=[O:15])[CH2:7]4)[CH2:3][CH2:2]3)=[CH:22][CH:21]=2)[S:27][N:26]=1Participants
4
Procedure
The object product (106 mg, 40%) was obtained in the same manner as in Example 1 and using spiro[indene-1,4′-piperidin]-3(2H)-one (190 mg), 3-chloro-6-(3-methyl-1,2,4-thiadiazol-5-yl)pyridazine (150 mg) and potassium carbonate (150 mg).
Sources & evidence
- ORD record
- ord-4a29d58cf41a49ffa8e20f26885528b9
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08575167B2
Reaction notes
Loading…